Clinicians, GPs & Nurses
Diagnosis Changes Lives. Don't Miss It.
FASD remains significantly underdiagnosed in the UK. SIGN 156 and NICE QS204 provide the current national framework for assessment, diagnosis, and care.
FASD Clinical Toolkit
Clinical Assessment Checklist
A printable checklist covering history, alcohol exposure, growth, the 10 areas, differentials, MDT and planning.
Open the checklist
Open the checklist
Clinical Quick Reference
When to consider FASD, what to gather, when to refer, and what to do when the alcohol history is unknown.
Open the quick reference
Open the quick reference
Professional Education
Clinical templates
Editable Word templates for referral letters, assessment records, MDT summaries, family feedback and management plans.
See the templates
See the templates
NICE QS204: Key Standards for Clinical Practice
📚 NICE Quality Standard QS204 (March 2022) is a quality standard for England. Wales, Scotland and Northern Ireland have their own arrangements. Quality standards describe high-quality care. They are not legal duties. The statements below use NICE’s own wording. SIGN 156 (2019, revalidated 2022) is the Scottish guideline. SIGN currently notes that some recommendations may be out of date.
1
QS1: Advice not to drink in pregnancy
“Pregnant women are given advice throughout pregnancy not to drink alcohol.”
2
QS2: Asking about and recording alcohol use
“Pregnant women are asked about their alcohol use throughout their pregnancy and this is recorded.”
Separately, SIGN 156 recommends validated tools such as T-ACE, TWEAK or AUDIT-C (see below).
Separately, SIGN 156 recommends validated tools such as T-ACE, TWEAK or AUDIT-C (see below).
3
QS3: Referral for assessment
“Children and young people with probable prenatal alcohol exposure and significant physical, developmental or behavioural difficulties are referred for assessment.”
4
QS4: Neurodevelopmental assessment
“Children and young people with confirmed prenatal alcohol exposure or all 3 facial features associated with prenatal alcohol exposure have a neurodevelopmental assessment if there are clinical concerns.”
5
QS5: Management plan
“Children and young people with a diagnosis of fetal alcohol spectrum disorder (FASD) have a management plan to address their needs.”
Source: NICE QS204 quality statements.
SIGN 156 Diagnostic Framework
📚 SIGN 156 (2019). Adopted by NICE QS204 as the underpinning diagnostic guideline for the UK.
FASD with Sentinel Facial Features
SNOMED CT: 1894471000000108
Requires all three sentinel facial features:
• Smooth philtrum: rank 4–5, University of Washington Lip-Philtrum Guide
• Thin vermillion border: rank 4–5, Lip-Philtrum Guide
• Short palpebral fissures: length ≥2 SD below the mean (SIGN 156 removed the percentile threshold because there are no UK norms)
Plus: PAE confirmed or unknown (not confirmed absent) and severe impairment in ≥3 of the 10 areas of assessment. In infants and young children, microcephaly (OFC <3rd centile) with all three sentinel features meets the CNS criterion.
Requires all three sentinel facial features:
• Smooth philtrum: rank 4–5, University of Washington Lip-Philtrum Guide
• Thin vermillion border: rank 4–5, Lip-Philtrum Guide
• Short palpebral fissures: length ≥2 SD below the mean (SIGN 156 removed the percentile threshold because there are no UK norms)
Plus: PAE confirmed or unknown (not confirmed absent) and severe impairment in ≥3 of the 10 areas of assessment. In infants and young children, microcephaly (OFC <3rd centile) with all three sentinel features meets the CNS criterion.
FASD without Sentinel Facial Features
SNOMED CT: 1894461000000101
Older terms such as pFAS, ARND and ARBD are no longer used in UK guidance. There is no equivalent category in ICD-10 or DSM-5.
Requires:
• Confirmed PAE: documented evidence of alcohol use in the index pregnancy (see Step 1 of the assessment pathway below)
• Pervasive brain dysfunction: severe impairment in ≥3 of the 10 SIGN 156 neurodevelopmental domains
Fewer than 3 sentinel facial features are present. This is not a milder diagnosis.
Older terms such as pFAS, ARND and ARBD are no longer used in UK guidance. There is no equivalent category in ICD-10 or DSM-5.
Requires:
• Confirmed PAE: documented evidence of alcohol use in the index pregnancy (see Step 1 of the assessment pathway below)
• Pervasive brain dysfunction: severe impairment in ≥3 of the 10 SIGN 156 neurodevelopmental domains
Fewer than 3 sentinel facial features are present. This is not a milder diagnosis.
At Increased Risk of FASD
SNOMED CT: 2078801000000102
For children who do not yet meet full criteria, for example confirmed PAE but child too young for full neurodevelopmental assessment, or 3 SFF present but assessment not yet complete. Should receive early support and regular re-assessment. Support should be based on need and should not wait for a diagnosis.
For children who do not yet meet full criteria, for example confirmed PAE but child too young for full neurodevelopmental assessment, or 3 SFF present but assessment not yet complete. Should receive early support and regular re-assessment. Support should be based on need and should not wait for a diagnosis.
SIGN 156: 10 Areas of Assessment
📚 Extracted directly from SIGN 156 Section 3.4. Severe impairment = global score or major subdomain score ≥2 SDs below the mean on a standardised measure. Impairment in ≥3 areas = pervasive brain dysfunction. "Domain" is used in SIGN 156 as an area of assessment.
SIGN 156 Screening Triggers
!
Consider FASD Assessment When:
• Child in foster, kinship, or adoptive care with unknown birth history
• Known or probable prenatal alcohol exposure at any level
• ADHD or ASD diagnosis not fully explaining the clinical picture, or not responding as expected
• Multiple failed placements, school exclusions, or placement breakdowns
• Unexplained learning difficulties with inconsistency in performance
• Three sentinel facial features identified on examination
• Comorbid mental health, conduct, or attachment disorder presentations
• Social services involvement in early life
• Known or probable prenatal alcohol exposure at any level
• ADHD or ASD diagnosis not fully explaining the clinical picture, or not responding as expected
• Multiple failed placements, school exclusions, or placement breakdowns
• Unexplained learning difficulties with inconsistency in performance
• Three sentinel facial features identified on examination
• Comorbid mental health, conduct, or attachment disorder presentations
• Social services involvement in early life
SIGN 156 Assessment Pathway
📚 SIGN 156 Sections 3.1–3.7. The diagnostic algorithm (Annex 2, SIGN 156) should be followed for all cases.
1
Gather PAE History
Confirmation of PAE requires documentation that the biological mother consumed alcohol during the index pregnancy based on: reliable clinical observation, self-report, reports by a reliable source, medical records of positive blood alcohol concentrations, or alcohol treatment / social / legal / medical problems related to drinking during the pregnancy. Unsubstantiated information, lifestyle alone, or history in previous pregnancies cannot in isolation confirm PAE in the index pregnancy.
2
Medical Examination
Assess all three sentinel facial features using the University of Washington Lip-Philtrum Guides. Measure palpebral fissure length (≥2 SDs below the mean per SIGN 156). Plot OFC, height, and weight on UK-WHO growth charts (available from SIGN website). Take a full family, social, and medical history. Obtain a three-generation family tree where possible to identify inheritable disorders. Other causes, including genetic conditions, should be considered as part of the assessment.
3
Note Associated Features (Not Diagnostic)
The following should be recorded but do not contribute to confirming or refuting an FASD diagnosis (per Canadian Rec. 3.2 adopted by SIGN 156): mid-face hypoplasia, micrognathia, abnormal ear position/formation, high arched palate, epicanthal folds, limb abnormalities, palmar crease abnormalities, short upturned nose. Growth impairment and congenital anomalies should also be documented if present.
4
Neurodevelopmental Assessment (MDT)
SIGN 156 MDT must include: neonatologist / paediatrician / physician with FASD competency; child development specialist with skill set for physical and functional assessments (e.g. speech and language therapist, occupational therapist, clinical or educational psychologist). Additional input may include clinical geneticist, physiotherapist, neuropsychologist, CAMHS, nurses, social workers, and family therapists. Assess across all 10 areas of brain function described in SIGN 156. Direct standardised measures should be used whenever possible.
5
Apply the Diagnostic Algorithm
Use the SIGN 156 Annex 2 diagnostic algorithm. For infants <6 years: if all 3 SFF + microcephaly → FASD with SFF; if all 3 SFF without microcephaly → refer to clinical geneticist + 'At Risk' designation; if PAE confirmed but criteria not met → 'At Risk'. If PAE is confirmed absent, FASD and 'At Risk' are not used. For older children: apply the full 10-domain assessment. Record SNOMED CT codes. Note: the diagnostic/descriptive criteria for FASD are the same for adults as for younger individuals (SIGN 156 Rec. 8.1).
6
Communicate and Develop Management Plan
Per NICE QS5 and SIGN 156 Section 4: Present findings to the family in writing and verbally. Use plain language appropriate to the child's age. The individualised management plan must address: basic and immediate needs, therapy services (SLT, OT, psychology), school adjustments, family support and psychoeducation, signposting to resources, and scheduled review. Reassessment at all transition points throughout the child's life.
Comorbidities: over 400 associated conditions
A systematic review identified 428 conditions that co-occur with FASD, across 18 of the 22 ICD-10 chapters (Popova et al., The Lancet, 2016). Common comorbidities explicitly listed in SIGN 156 include ADHD, ASD features, and mood disorders. Also frequently seen: anxiety disorders, conduct disorder, attachment disorders, sleep disorders, substance misuse in adolescence/adulthood, and involvement in the judicial system. Treat the whole child and coordinate care across agencies.
Screening Tools for PAE in Pregnancy
Per SIGN 156 Recommendations 2.3 and 2.4: use a validated tool (T-ACE, TWEAK or AUDIT-C) to screen all pregnant women for alcohol consumption. Consider associated biomarkers (CDT, PEth) alongside questionnaires. Document dose, pattern, and frequency of alcohol use. PAE information (confirmed / confirmed absent / unknown) must remain accessible in the child's health records throughout childhood.
Official SIGN 156 Downloads
📚 Free from the SIGN website. Use these alongside the summaries above.
Guideline and diagnostic tools
• SIGN 156 full guideline (PDF)
• Diagnostic algorithm for FASD (PDF)
• Neurodevelopmental areas of assessment: criteria for severe impairment (PDF), with example standardised tests for each area
• Information for clinicians (PDF) and after diagnosis (PDF)
• Diagnostic algorithm for FASD (PDF)
• Neurodevelopmental areas of assessment: criteria for severe impairment (PDF), with example standardised tests for each area
• Information for clinicians (PDF) and after diagnosis (PDF)
Templates and growth charts
FASD Training for Clinicians
🎓 Course details checked on 3 November 2026. Always check the provider's website for current dates and fees.
RCPCH FASD Masterclass
The RCPCH FASD Masterclass is held yearly by the Royal College of Paediatrics and Child Health. Its course title is How to Manage: FASD in Community Paediatric Services. It teaches how to assess and diagnose FASD within a local child development service.
It covers:
It covers:
- taking a full antenatal history, including alcohol and drugs
- assessing facial and other physical features
- assessing the CNS areas and forming a diagnosis
- adverse childhood experiences and other exposures
- support after diagnosis, and the parent and carer perspective
RCPCH genomics webinar
A recorded RCPCH webinar from May 2025 on genomics in paediatrics includes current approaches to FASD and genetic testing. Find it on the RCPCH genomics page.
More courses
National FASD runs eSchool courses and a free CPD-accredited e-course for maternity teams. See the National FASD section below.
Training and Resources from National FASD
🤝 National FASD provides free resources and training for health professionals.
GPs and healthcare professionals
Guidance on prevention, recognition, referral, diagnosis, support and SNOMED coding, with the "Recognising FASD" pamphlet and "FASD in Focus: Diagnosis & Assessments". Visit the GP and healthcare page.
Midwives and maternity teams
The Alcohol and Pregnancy Toolkit includes a free, CPD-accredited e-course for maternity teams, leaflets, posters and a tabletop guide to support conversations about alcohol in pregnancy. The maternity teams page covers recording alcohol use and the ASSIST framework.
Courses and expert talks
The National FASD eSchool offers "Introduction to FASD", "Alcohol and Pregnancy for Maternity Teams" and "Talking About Alcohol and Pregnancy for Practitioners". See training options.
Raja and Neil's FASD Book Club has free video talks from UK experts, including standardising FASD diagnosis, psychometric assessment, and assessment at birth and in infancy.
For bespoke training, email training@nationalfasd.org.uk.
Raja and Neil's FASD Book Club has free video talks from UK experts, including standardising FASD diagnosis, psychometric assessment, and assessment at birth and in infancy.
For bespoke training, email training@nationalfasd.org.uk.